Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Metaplasia

• Metformin Efficacy and Safety for Gastric Intestinal Metaplasia
• Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor
• The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study
• The Efficacy of Severe Whitening and Delayed Fading in Acetic Acid-enhanced Endoscopy for Diagnosing Gastric Intestinal Metaplasia
• Chemoprevention of Gastric Carcinogenesis
• Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
• Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia
• Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
• Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder
• Tamoxifen to Treat Barrett's Metaplasia
• Effect of Zinc on Barrett's Metaplasia
• Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery
• Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
• Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung
• A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
• A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
• A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia
• Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia
• A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
• A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)
• Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
• S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
• Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor
• A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)
• PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP
• Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)
• RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
• Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia